Gynecologie Obstetrique Fertilite & Senologie, published by ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER, serves as a crucial resource for researchers and practitioners in the fields of obstetrics, gynecology, and reproductive medicine. Established in 2017 and continuing through 2024, this journal provides a platform for the dissemination of impactful research, evidenced by its placement in the Q3 category for both obstetrics and gynecology and reproductive medicine in 2023. Although it currently does not operate under an open-access model, the journal is committed to advancing knowledge and practice in women's health and reproductive issues, ensuring that professionals stay at the forefront of scientific developments. With an ISSN of 2468-7197 and an E-ISSN of 2468-7189, the journal not only supports the global medical community from its base in France but also contributes to the broader academic discourse on critical topics such as fertility and women's health. As researchers and professionals in the field seek to enhance their understanding and impact, Gynecologie Obstetrique Fertilite & Senologie remains an essential publication for quality research and innovative solutions in women’s health.

Reproductive Biomedicine Online, published by Elsevier, is a leading peer-reviewed journal that has established itself as a pivotal resource in the fields of Developmental Biology, Obstetrics and Gynecology, and Reproductive Medicine. With an impressive Impact Factor and a Q1 ranking in its respective disciplines as of 2023, this journal provides a platform for innovative research and comprehensive reviews that contribute to advancements in reproductive healthcare. The journal boasts rigorous Scopus rankings, placing it within the top tiers of its categories, which underscores its significance in shaping contemporary biomedical inquiry. Although not open access, it remains widely accessible through institutional subscriptions, making its wealth of knowledge available to researchers, clinicians, and students alike. Since its inception in 2000, Reproductive Biomedicine Online has been committed to fostering a deeper understanding of reproductive processes and biomedicine, ensuring that its content remains relevant and impactful in addressing challenges in reproductive health, thereby championing exceptional scientific discourse.

The International Journal of Fertility & Sterility, published by ROYAN Institute, is a leading academic platform dedicated to advancing knowledge in the fields of obstetrics, gynecology, and reproductive medicine. With an ISSN of 2008-076X and an E-ISSN of 2008-0778, this Open Access journal has been making significant contributions to the scientific community since its inception in 2007. Based in Tehran, Iran, the journal showcases rigorous research and promotes interdisciplinary collaboration, addressing critical topics related to fertility, sterility, and reproductive health. As of 2023, it holds an impressive Q2 ranking in Obstetrics and Gynecology and a Q3 ranking in Reproductive Medicine, underscoring its relevance and impact in the academic sphere, with Scopus ranks placing it at #67 in Obstetrics and Gynecology and #32 in Reproductive Medicine. The journal's commitment to accessibility and quality is reflected in its global readership, making it an essential resource for researchers, healthcare professionals, and students seeking to enhance their understanding of fertility issues and reproductive technologies.

GEBURTSHILFE UND FRAUENHEILKUNDE is a prestigious journal dedicated to the fields of Maternity, Midwifery, Obstetrics, and Gynecology, published by GEORG THIEME VERLAG KG, a reputable publisher known for its commitment to advancing medical knowledge. Established in 1947, the journal has consistently provided a platform for high-quality research and clinical studies that address current challenges and innovations in women's health. With an impact factor positioned in Q2 for Maternity and Midwifery and Q3 in Obstetrics and Gynecology, it ranks among the top journals within its field, further solidified by its Scopus rankings highlighting its influential presence. Although the journal is not open access, it remains an essential resource for academics and practitioners keen to stay informed on the latest evidence-based practices and cutting-edge research, ensuring that all stakeholders in women's healthcare can access critical insights to enhance patient outcomes.

MOLECULAR REPRODUCTION AND DEVELOPMENT is a prestigious peer-reviewed journal published by WILEY, specializing in the intricate domains of Cell Biology, Developmental Biology, and Genetics. Since its inception in 1988, this journal has been a vital platform for disseminating pioneering research and innovative methodologies that advance our understanding of molecular mechanisms driving reproduction and development. With a current impact factor reflective of its significance in the field, MOLECULAR REPRODUCTION AND DEVELOPMENT is ranked Q3 in both Cell Biology and Developmental Biology, and Q2 in Genetics, underscoring its relevance and scholarly contribution. Catering to a diverse audience of researchers, professionals, and students, this journal not only showcases cutting-edge findings but also aims to foster interdisciplinary exchanges that enhance scientific collaboration. By exploring critical biological processes, it ultimately contributes to the broader understanding of health and disease in various organisms, making it an essential resource for anyone dedicated to the life sciences.

Gynakologische Endokrinologie is a pivotal journal published by SPRINGER HEIDELBERG, dedicated to advancing the fields of endocrinology, obstetrics, gynecology, reproductive medicine, and pediatrics. With an ISSN of 1610-2894, this journal serves as a valuable platform for researchers and practitioners to disseminate their findings and explore emerging trends and treatments in the realm of women's health and endocrine disorders. Though currently positioned in the Q4 quartile across relevant categories, its mission is to foster scholarly discourse that bridges gaps in knowledge and enhances clinical practices. With a commitment to quality research, it provides a forum for innovative studies and case reports that could influence future healthcare strategies. Positioned in Germany, Gynakologische Endokrinologie aims to cater to a global audience, enhancing knowledge and collaboration in critical areas impacting women's health and hormone-related conditions.

Reproductive Sciences is a premier journal published by SPRINGER HEIDELBERG, dedicated to the field of obstetrics and gynecology. With its ISSN 1933-7191 and E-ISSN 1933-7205, the journal has established itself as a leading source of high-quality research and clinical insights since its inception in 2007, and continues to converge its scope into 2024. Currently ranked in the Q1 category for obstetrics and gynecology, it holds the 43rd position among 209 journals in the Scopus rankings, underscoring its influence and relevance within the medical community. This journal is particularly dedicated to advancing knowledge in reproductive health, providing a platform for innovative research and clinical practices through both traditional and open access options. Located in Switzerland with an address in Heidelberg, Germany, Reproductive Sciences is not just a publication; it is a vital resource for researchers, professionals, and students seeking to make impactful contributions to the field of reproductive health.

Fertility and Sterility is a prestigious peer-reviewed journal dedicated to the fields of obstetrics, gynecology, and reproductive medicine. Published by Elsevier Science Inc, this journal has been a cornerstone of scientific discourse since its inception in 1950 and is set to continue its influential coverage of cutting-edge research until 2024. Boasting an impressive impact factor, Fertility and Sterility is ranked among the top-tier journals in its category, holding Q1 status in both Obstetrics and Gynecology and Reproductive Medicine. With Scopus rankings placing it in the 97th and 96th percentiles respectively, the publication serves as a vital resource for researchers, clinicians, and students who seek to advance their understanding of fertility issues and reproductive health. Although it does not currently offer open access options, the journal remains committed to disseminating high-quality research and innovative solutions to the complex challenges in reproduction, empowering professionals and scholars to make meaningful contributions in their fields.

MOLECULAR HUMAN REPRODUCTION, published by Oxford University Press, is a pivotal journal dedicated to advancing the field of reproductive biology. Since its inception in 1995, the journal has been recognized for its rigorous peer-reviewed research and substantial contributions to the understanding of molecular mechanisms underlying human reproduction. With an impressive impact factor and ranked within the top tiers (Q1 and Q2) across diverse categories including Embryology, Obstetrics and Gynecology, and Reproductive Medicine, it stands as an essential resource for researchers, healthcare professionals, and students alike. The journal aims to publish cutting-edge research that explores the complexities of human reproduction at the molecular and cellular levels, fostering a deeper understanding that can be translated into clinical practice. Although it currently operates under a subscription model, the valuable insights and groundbreaking findings featured within its pages continue to influence the trajectory of reproductive health research globally. Located in the heart of Oxford, United Kingdom, the journal remains committed to addressing vital challenges in the field and promoting innovative scientific dialogue.

Reproduction, Fertility and Development, published by CSIRO Publishing, is a prestigious journal that has been at the forefront of research in the fields of reproductive science, developmental biology, and related disciplines since its inception in 1989. With an ISSN of 1031-3613 and an E-ISSN of 1448-5990, this journal serves as a vital platform for disseminating innovative findings and methodologies that advance our understanding of reproductive processes and development in a variety of organisms. The journal is indexed in prominent databases, exhibiting a solid standing with a Q3 quartile ranking in both Animal Science and Zoology and Biotechnology, and covering 2023 rankings in multiple related categories. Operating from Australia, Reproduction, Fertility and Development embraces a commitment to enriching scholarly communication and fostering collaborative research efforts. Its focus on high-quality, peer-reviewed articles makes it an essential resource for researchers, professionals, and students seeking to stay abreast of the latest advancements and pivotal discussions in reproductive medicine and developmental biology.